These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3525809)

  • 1. Antenatal prevention of the neonatal respiratory distress syndrome: benefits and potential risks for the mother and the infant.
    Papageorgiou A; Stern L
    J Perinat Med; 1986; 14(2):75-86. PubMed ID: 3525809
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention and treatment of fetal lung immaturity.
    Cosmi EV; Di Renzo GC
    Fetal Ther; 1989; 4 Suppl 1():52-62. PubMed ID: 2577304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The current status of inducing fetal lung maturity for prevention of neonatal respiratory distress syndrome].
    Ragosch V; Weitzel H
    Gynakologe; 1995 Jun; 28(3):203-10. PubMed ID: 7657182
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternatives to the antenatal glucocorticoid treatment for the prevention of respiratory distress syndrome.
    Dudenhausen JW
    J Perinat Med; 1987; 15(5):453-9. PubMed ID: 3443900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current potentials for the antenatal prevention of the idiopathic respiratory distress syndrome].
    Marinov B; Ruseva R
    Akush Ginekol (Sofiia); 1983; 22(4):330-3. PubMed ID: 6322606
    [No Abstract]   [Full Text] [Related]  

  • 6. Lung surfactant enhancement in utero.
    Di Renzo GC; Anceschi MM; Cosmi EV
    Eur J Obstet Gynecol Reprod Biol; 1989 Jul; 32(1):1-11. PubMed ID: 2670624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of pediatric respiratory distress syndrome with special reference to glucocorticoids].
    Gerner R
    Med Klin (Munich); 1990 Mar; 85(3):151-5. PubMed ID: 2186262
    [No Abstract]   [Full Text] [Related]  

  • 8. Antenatal ambroxol usage in the prevention of infant respiratory distress syndrome. Beneficial and adverse effects.
    Kimya Y; Küçükkömürcü S; Ozan H; Uncu G
    Clin Exp Obstet Gynecol; 1995; 22(3):204-11. PubMed ID: 7554258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The status of drug prevention of respiratory distress syndrome in German gynecologic clinics].
    Knitza R; Linke M; Wisser J; Hepp H
    Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):345-9. PubMed ID: 2737429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoiding the prenatal programming effects of glucocorticoids: are there alternative treatments for the induction of antenatal lung maturation?
    Justus G; Sloboda DM; Henrich W; Plagemann A; Dudenhausen JW; Braun T
    J Perinat Med; 2015 Sep; 43(5):503-23. PubMed ID: 25405717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements of perinatal prevention and treatment of respiratory distress syndrome.
    Di Renzo GC; Anceschi MM; Guidetti R; Cosmi EV
    Eur Respir J Suppl; 1989 Mar; 3():68s-72s. PubMed ID: 2662998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New frontiers in prenatal prevention of respiratory distress syndrome.
    Cosmi EV
    J Perinat Med; 1991; 19 Suppl 1():170-5. PubMed ID: 1779354
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of hyaline membrane disease].
    Gerber A
    Monatsschr Kinderheilkd; 1986 Sep; 134(9):662-5. PubMed ID: 3785233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of respiratory distress syndrome.
    Moya FR; Gross I
    Semin Perinatol; 1988 Oct; 12(4):348-58. PubMed ID: 3146813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dilemmas about the antenatal use of corticosteroids for prevention of neonatal morbidity and mortality].
    Grgić O; Matijević R
    Acta Med Croatica; 2005; 59(2):129-35. PubMed ID: 15909887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems in inducing pulmonary maturation in relation to premature delivery].
    Mĕchurová A
    Ceska Gynekol; 2000 Dec; 65 Suppl 1():50-4. PubMed ID: 11394234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The status of prenatal lung ripening].
    Wolff F; Bolte A
    Geburtshilfe Frauenheilkd; 1990 Mar; 50(3):171-6. PubMed ID: 2187733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ambroxol versus betamethasone for the promotion of antepartum lung maturity in pathological pregnancies].
    Heytmanek G; Salzer H; Vityska-Binstorfer E; Genger H; Metka M; Pfersmann R; Wolff F; Weidinger H
    Wien Klin Wochenschr; 1990 Aug; 102(15):443-8. PubMed ID: 2402930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lung maturation therapy with glucocorticoids in threatened premature labor. Considerations of risk-benefit in evidence-based medicine].
    Sauerwald A; Rath W
    Z Geburtshilfe Neonatol; 2000; 204(6):203-9. PubMed ID: 11199148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic prospectives in respiratory distress syndrome and their immuno-endocrinologic correlates].
    Caramia G; Rossi R; Palumbo P; Mocchegiani E; Fabris N
    Minerva Pediatr; 1986 Sep; 38(17-18):707-11. PubMed ID: 3796528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.